SCHEMBL2012252

SCHEMBL2012252

CCCCCCCC=CC=COC(=O)C(C)C

nearest known ligand 0.53

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
FASN P49327 1/20 0.53
CNR1 P21554 1/20 0.50
CNR2 P34972 1/20 0.50
FAAH O00519 4/20 0.49
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46
PPARG P37231 2/20 0.46
GPR132 Q9UNW8 1/20 0.46
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4965109 0.88 PPARG (0.44) CNR1ALDH1A1PPARGKDM4EMEN1
SCHEMBL19810207 0.86 PTPN2 (0.36) FASNCNR1CNR2FAAHALDH1A1
SCHEMBL19810206 0.86 PTPN2 (0.36) FASNCNR1CNR2FAAHALDH1A1
SCHEMBL405977 0.82 F7 (0.40) CNR1FAAHALDH1A1PPARGKDM4E
SCHEMBL9069428 0.82 FASN (0.59) FASNFAAHALDH1A1TSHRPPARG
SCHEMBL9069432 0.82 FASN (0.59) FASNFAAHALDH1A1TSHRPPARG
SCHEMBL15621210 0.82 F7 (0.40) CNR1FAAHALDH1A1PPARGKDM4E
SCHEMBL405976 0.82 F7 (0.40) CNR1FAAHALDH1A1PPARGKDM4E
SCHEMBL28158676 0.81 FASN (0.50) FASNCNR1CNR2FAAHALDH1A1
SCHEMBL593380 0.81 FASN (0.58) FASNFAAHALDH1A1TSHRPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240180219-A1 SEAMLESS CAPSULE STABLY DISINTEGRABLE EVEN IN HIGH-TEMPERATURE AND HIGH-HUMIDITY ENVIRONMENT, AND METHOD FOR PRODUCING THE SAME MORISHITA JINTAN CO., LTD. (JP) 2024-06-06 US disclosed
EP-3888475-B1 SEAMLESS CAPSULE, AND FILTER AND SMOKING DEVICE INCLUDING SAME SUNSHO PHARMACEUTICAL CO LTD (JP) 2024-04-10 EP disclosed
EP-4316472-A1 DISINTEGRABLE SEAMLESS CAPSULE THAT IS STABLE EVEN IN HIGH-TEMPERATURE AND HIGH-HUMIDITY ENVIRONMENT, AND METHOD FOR PRODUCING SAID SEAMLESS CAPSULE Morishita Jintan Co., Ltd. (JP) 2024-02-07 EP disclosed
EP-3888475-A1 SEAMLESS CAPSULE, AND FILTER AND SMOKING DEVICE INCLUDING SAME Sunsho Pharmaceutical Co.Ltd (JP) 2021-10-06 EP disclosed
US-20210122693-A1 DIENAL COMPOUND AND FLAVOR COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2021-04-29 US disclosed
EP-3792242-A1 DIENAL COMPOUND AND PERFUME COMPOSITION Takasago International Corporation (JP) 2021-03-17 EP disclosed
US-10905156-B2 Seamless capsule, filter and smoking equipment containing same SUNSHO PHARMACEUTICAL CO., LTD. 2021-02-02 US disclosed
US-20200397038-A1 Seamless capsule, filter and smoking equipment containing same SUNSHO PHARMACEUTICAL CO., LTD. (JP) 2020-12-24 US disclosed
EP-3711497-A1 SEAMLESS CAPSULE, AND FILTER AND SMOKING DEVICE INCLUDING SAME Sunsho Pharmaceutical Co., Ltd. (JP) 2020-09-23 EP disclosed
WO-2020148924-A1 SEAMLESS CAPSULE, AND FILTER AND SMOKING DEVICE INCLUDING SAME 三生医薬株式会社 2020-07-23 WO disclosed
US-20150257421-A1 SHRIMP FLAVOR COMPOSITION AND SHRIMP FLAVOR ENHANCER TAKASAGO INTERNATIONAL CORPORATION (JP) 2015-09-17 US disclosed
US-20150257423-A1 CHICKEN FLAVOR COMPOSITION AND CHICKEN FLAVOR ENHANCER TAKASAGO INTERNATIONAL CORPORATION (JP) 2015-09-17 US disclosed
EP-2904908-A1 CHICKEN FLAVOR COMPOSITION AND CHICKEN TASTE ENHANCER Takasago International Corporation (JP) 2015-08-12 EP disclosed
EP-2904909-A1 SHRIMP FLAVOR COMPOSITION AND SHRIMP FLAVOR ENHANCER Takasago International Corporation (JP) 2015-08-12 EP disclosed
US-20140163099-A1 ANTIMICROBIAL COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2014-06-12 US disclosed
EP-2725900-A1 ANTIMICROBIAL COMPOSITION Takasago International Corporation (JP) 2014-05-07 EP disclosed
WO-2013002421-A1 ANTIMICROBIAL COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2013-01-03 WO disclosed
US-20130005807-A1 ANTIMICROBIAL COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2013-01-03 US disclosed
US-7964637-B2 Process for producing optically active theaspirane TAKASAGO INTERNATIONAL CORPORATION (JP) 2011-06-21 US disclosed
US-20090270516-A1 Process for Producing Optically Active Theaspirane TAKASAGO INTERNATIONAL CORPORATION (JP) 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270516-A1 Process for Producing Optically Active Theaspirane DHPS, ALDH7A1, FASN FASN 3/4885CNR1 3652/4885CNR2 3618/4885
US-20210122693-A1 DIENAL COMPOUND AND FLAVOR COMPOSITION OR10J3, TAS2R5, TAS2R4 FASN 103/4885CNR1 1881/4885CNR2 1962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.